Literature DB >> 30231434

Defining Patient-Centricity: Opportunities, Challenges, and Implications for Clinical Care and Research.

Dennis A Robbins1,2, Frederick A Curro2,3,4, Chester H Fox5,6.   

Abstract

The Patient-Centered Outcomes Research Institute (PCORI), created and funded by the Affordable Care Act, is charged with bringing the patient perspective to clinical research design and the outcomes that are studied. However, there is no consensus definition of "patient-centeredness" or "patient-centricity." This paper distinguishes between the terms and describes an infrastructure for supporting the concept of patient-centricity. The patient's role needs to be described in a way that makes it feasible to implement health care delivery and support parameters to conduct clinical research over a sustained period of time. The authors propose the use of a structured Practice-Based Clinical Research Network to perform patient-centered outcomes research consistent with the requirements of the pharmaceutical sector in a safe, ethical, and effective manner and congruent with the principles of Good Clinical Practice (GCP).

Entities:  

Keywords:  CER; PBRN; PCORI; centricity; health literacy; patient-centered; patient-centric; patient-centricity

Year:  2013        PMID: 30231434     DOI: 10.1177/2168479013484159

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  7 in total

Review 1.  Who is at the centre of what? A scoping review of the conceptualisation of 'centredness' in healthcare.

Authors:  Elizabeth Ann Sturgiss; Annette Peart; Lauralie Richard; Lauren Ball; Liesbeth Hunik; Tze Lin Chai; Steven Lau; Danny Vadasz; Grant Russell; Moira Stewart
Journal:  BMJ Open       Date:  2022-05-02       Impact factor: 3.006

2.  Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions.

Authors:  Seol Ju Moon; Song-Hee Han; Yong-Geun Kwak; Min-Gul Kim
Journal:  Transl Clin Pharmacol       Date:  2022-03-17

3.  Stakeholders' views on drug development: the congenital disorders of glycosylation community perspective.

Authors:  Maria Monticelli; Rita Francisco; Sandra Brasil; Dorinda Marques-da-Silva; Tatiana Rijoff; Carlota Pascoal; Jaak Jaeken; Paula A Videira; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

4.  Defining patient centricity with patients for patients and caregivers: a collaborative endeavour.

Authors:  Guy Yeoman; Patricia Furlong; Michael Seres; Helena Binder; Helena Chung; Vincenzo Garzya; Rachel Rm Jones
Journal:  BMJ Innov       Date:  2017-03-24

Review 5.  Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review.

Authors:  Carlota Pascoal; Sandra Brasil; Rita Francisco; Dorinda Marques-da-Silva; Agnes Rafalko; Jaak Jaeken; Paula A Videira; Luísa Barros; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2018-11-28       Impact factor: 4.123

6.  WHO guidance for digital health: What it means for researchers.

Authors:  Tarveen Jandoo
Journal:  Digit Health       Date:  2020-01-08

7.  The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ).

Authors:  Rita Francisco; Sandra Brasil; Carlota Pascoal; Jaak Jaeken; Merell Liddle; Paula A Videira; Vanessa Dos Reis Ferreira
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.